tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MUFG Acquires Substantial Holding in Australian Clinical Labs

Story Highlights
  • MUFG, through First Sentier, holds a substantial stake in Australian Clinical Labs.
  • This acquisition may impact Australian Clinical Labs’ market positioning and stakeholder interests.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
MUFG Acquires Substantial Holding in Australian Clinical Labs

Claim 70% Off TipRanks This Holiday Season

An announcement from Australian Clinical Labs Ltd ( (AU:ACL) ) is now available.

Australian Clinical Labs Ltd has announced a substantial holding by Mitsubishi UFJ Financial Group (MUFG) through its subsidiary, First Sentier Investors Holdings Pty Limited. This development signifies a notable shift in the company’s shareholder structure, potentially impacting its market positioning and stakeholder interests, as MUFG now holds significant voting power in the company.

More about Australian Clinical Labs Ltd

YTD Price Performance: -11.76%

Average Trading Volume: 872,541

Technical Sentiment Signal: Buy

Current Market Cap: A$596.3M

For a thorough assessment of ACL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1